RNC Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $15.1M | Sell |
14,065
-564
| -4% | -$539K | 0.69% | 39 |
|
|
2025
Q3 | $11.2M | Buy |
14,629
+2,041
| +16% | +$1.52M | 0.51% | 42 |
|
|
2025
Q2 | $9.81M | Sell |
12,588
-295
| -2% | -$229K | 0.48% | 44 |
|
|
2025
Q1 | $10.6M | Sell |
12,883
-286
| -2% | -$238K | 0.54% | 41 |
|
|
2024
Q4 | $10.2M | Sell |
13,169
-743
| -5% | -$615K | 0.54% | 40 |
|
|
2024
Q3 | $12.6M | Hold |
13,912
| – | – | 0.7% | 37 |
|
|
2024
Q2 | $12.6M | Buy |
13,912
+671
| +5% | +$537K | 0.7% | 37 |
|
|
2024
Q1 | $10.3M | Sell |
13,241
-1,646
| -11% | -$1.17M | 0.59% | 38 |
|
|
2023
Q4 | $8.68M | Sell |
14,887
-103
| -0.7% | -$60.1K | 0.52% | 39 |
|
|
2023
Q3 | $8.05M | Sell |
14,990
-367
| -2% | -$189K | 0.5% | 38 |
|
|
2023
Q2 | $7.2M | Sell |
15,357
-142
| -0.9% | -$59.6K | 0.4% | 43 |
|
|
2023
Q1 | $5.32M | Buy |
15,499
+2,299
| +17% | +$775K | 0.3% | 48 |
|
|
2022
Q4 | $4.83M | Sell |
13,200
-1,161
| -8% | -$412K | 0.27% | 53 |
|
|
2022
Q3 | $4.64M | Sell |
14,361
-1,294
| -8% | -$410K | 0.29% | 53 |
|
|
2022
Q2 | $5.08M | Buy |
15,655
+65
| +0.4% | +$19.5K | 0.29% | 52 |
|
|
2022
Q1 | $4.46M | Sell |
15,590
-219
| -1% | -$56.4K | 0.23% | 70 |
|
|
2021
Q4 | $4.37M | Sell |
15,809
-1
| -0% | -$254 | 0.22% | 73 |
|
|
2021
Q3 | $3.65M | Sell |
15,810
-1,255
| -7% | -$310K | 0.19% | 74 |
|
|
2021
Q2 | $3.92M | Sell |
17,065
-2,964
| -15% | -$595K | 0.21% | 71 |
|
|
2021
Q1 | $3.74M | Sell |
20,029
-3,823
| -16% | -$748K | 0.21% | 71 |
|
|
2020
Q4 | $4.03M | Sell |
23,852
-2,357
| -9% | -$352K | 0.25% | 66 |
|
|
2020
Q3 | $3.88M | Sell |
26,209
-3,231
| -11% | -$500K | 0.28% | 59 |
|
|
2020
Q2 | $4.83M | Sell |
29,440
-192,272
| -87% | -$29.5M | 0.35% | 48 |
|
|
2020
Q1 | $30.8M | Sell |
221,712
-5,163
| -2% | -$709K | 2.62% | 14 |
|
|
2019
Q4 | $29.8M | Buy |
226,875
+12,682
| +6% | +$1.47M | 1.88% | 25 |
|
|
2019
Q3 | $24M | Sell |
214,193
-7,147
| -3% | -$796K | 1.7% | 30 |
|
|
2019
Q2 | $24.5M | Sell |
221,340
-543
| -0.2% | -$63.9K | 1.7% | 31 |
|
|
2019
Q1 | $28.8M | Sell |
221,883
-253,939
| -53% | -$30.9M | 2.01% | 30 |
|
|
2018
Q4 | $55.1M | Sell |
475,822
-858
| -0.2% | -$95.8K | 4.16% | 3 |
|
|
2018
Q3 | $51.2M | Buy |
476,680
+2,813
| +0.6% | +$281K | 3.38% | 6 |
|
|
2018
Q2 | $40.4M | Buy |
473,867
+4,871
| +1% | +$400K | 2.85% | 13 |
|
|
2018
Q1 | $36.3M | Buy |
468,996
+3,561
| +0.8% | +$287K | 2.68% | 19 |
|
|
2017
Q4 | $39.3M | Buy |
465,435
+4,832
| +1% | +$411K | 2.72% | 15 |
|
|
2017
Q3 | $39.4M | Buy |
460,603
+7,737
| +2% | +$635K | 2.97% | 11 |
|
|
2017
Q2 | $37.3M | Buy |
452,866
+28,133
| +7% | +$2.3M | 2.88% | 10 |
|
|
2017
Q1 | $35.7M | Buy |
424,733
+135,481
| +47% | +$10.9M | 2.85% | 10 |
|
|
2016
Q4 | $21.3M | Sell |
289,252
-134,092
| -32% | -$9.99M | 1.76% | 29 |
|
|
2016
Q3 | $34M | Buy |
423,344
+12,560
| +3% | +$1.01M | 3.02% | 7 |
|
|
2016
Q2 | $32.3M | Buy |
410,784
+122,237
| +42% | +$9.2M | 3.02% | 8 |
|
|
2016
Q1 | $20.8M | Buy |
288,547
+12,142
| +4% | +$919K | 2.05% | 23 |
|
|
2015
Q4 | $23.3M | Buy |
+276,405
| New | +$22.9M | 2.34% | 15 |
|
Other funds holding LLY
RNC Capital Management's LLY Position: Q4 2025 in Review
RNC Capital Management reduced its Eli Lilly (LLY) stake by 3.9% in Q4 2025, selling an estimated $539K and leaving 14,065 shares worth $15.1M. The position accounts for 0.69% of the portfolio, ranked #39.
RNC Capital Management first reported a position in LLY in Q4 2015 and has held it in 41 quarters since. The position peaked at $55.1M in Q4 2018. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- RNC Capital Management held 14,065 shares of Eli Lilly worth $15.1M as of Q4 2025.
- RNC Capital Management sold 564 Eli Lilly shares in Q4 2025, an estimated $539K.
- Eli Lilly made up 0.69% of RNC Capital Management's portfolio in Q4 2025, its #39 holding.
- RNC Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 41 quarters since.
- RNC Capital Management's Eli Lilly position peaked at $55.1M in Q4 2018.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.